09/15/2025
3:47 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2025
3:13 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/02/2025
4:20 PM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/02/2025
3:36 PM | Cytokinetics (Subject)
Harrington Robert Arthur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/02/2025
3:41 PM | Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2025
6:57 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2025
6:58 AM | Cytokinetics (Issuer)
Daly James M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/20/2025
7:04 AM | Cytokinetics (Issuer)
Daly James M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2025
9:16 AM | Cytokinetics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
08/05/2025
5:28 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2025
10:01 AM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CYTK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cytokinetics and its competitors with MarketBeat's FREE daily newsletter. |
07/16/2025
4:41 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
4:43 PM | Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
4:44 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
4:45 PM | Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
4:48 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2025
4:38 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2025
3:21 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2025
3:22 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2025
3:27 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
4:19 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
3:21 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2025
5:51 PM | Bhanji Muna (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
5:46 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
6:23 PM | Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
6:25 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
6:27 PM | Cytokinetics (Issuer)
Landry Robert E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
6:35 PM | Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
6:40 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
6:42 PM | Bhanji Muna (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2025
9:37 AM | Cytokinetics (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
| Form SCHEDULE 13G | |
05/06/2025
3:30 PM | Cytokinetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2025
3:37 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
5:21 PM | Callos Andrew (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
3:15 PM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2025
3:33 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:42 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
3:14 PM | Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2025
3:25 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2025
3:32 PM | Cytokinetics (Subject)
HENDERSON JOHN T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2025
4:40 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/10/2025
6:30 AM | Cytokinetics (Filer)
| Form DEF 14A | |
04/10/2025
6:31 AM | Cytokinetics (Filer)
| Form ARS | |
04/08/2025
5:02 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2025
4:03 PM | Callos Andrew (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2025
3:24 PM | Callos Andrew (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/31/2025
9:29 AM | Cytokinetics (Filer)
| Form PRE 14A | |
03/19/2025
5:03 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:29 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:17 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:20 PM | Callos Andrew (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:08 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
7:19 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
7:21 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
7:23 PM | Callos Andrew (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
3:36 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
7:53 PM | Callos Andrew (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:26 PM | Callos Andrew (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2025
3:32 PM | Callos Andrew (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
6:30 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
7:39 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
7:41 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
7:43 PM | Callos Andrew (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:43 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:06 PM | Cytokinetics (Subject)
Harrington Robert Arthur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
4:24 PM | Cytokinetics (Filer)
| Form S-3ASR | |
02/12/2025
8:28 AM | Cytokinetics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/11/2025
7:26 AM | Cytokinetics (Issuer)
Landry Robert E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
7:18 AM | Cytokinetics (Issuer)
Landry Robert E (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/11/2025
6:30 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
3:31 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:25 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
10:29 AM | Cytokinetics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/07/2025
3:17 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
3:22 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:23 PM | Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:25 PM | Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:25 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:27 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
6:23 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:38 PM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
3:13 PM | Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
9:17 AM | Cytokinetics (Subject)
HENDERSON JOHN T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
4:42 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:30 PM | Cytokinetics (Issuer)
Lee Sung (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:32 PM | Cytokinetics (Issuer)
Wong Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:22 PM | Callos Andrew (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:28 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
5:46 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:01 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
6:05 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/26/2024
4:38 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:10 PM | Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
5:02 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:04 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
8:55 AM | Cytokinetics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/04/2024
4:45 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
10:17 AM | Cytokinetics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024
3:43 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:45 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
